Treatment FAQ

how to treatment graves orbitopathy

by Mr. Frederick Koss II Published 3 years ago Updated 2 years ago
image

  • Corticosteroids. Treatment with corticosteroids, such as prednisone, may lessen swelling behind your eyeballs. ...
  • Teprotumumab (Tepezza). This medication may be used to treat Graves' ophthalmopathy. It's given through an IV in the arm every three weeks and is given eight times. ...
  • Prisms. You may have double vision either because of Graves' disease or as a side effect of surgery for Graves' disease. ...
  • Orbital decompression surgery. In this surgery, your doctor removes the bone between your eye socket (orbit) and your sinuses — the air spaces next to the orbit. ...
  • Orbital radiotherapy. This was once a common treatment for this condition, but the benefits aren't clear. ...

Treating Graves' ophthalmopathy
  1. Corticosteroids. Treatment with corticosteroids, such as prednisone, may lessen swelling behind your eyeballs. ...
  2. Teprotumumab (Tepezza). This medication may be used to treat Graves' ophthalmopathy. ...
  3. Prisms. ...
  4. Orbital decompression surgery. ...
  5. Orbital radiotherapy.

What doctor treats Graves' disease?

Thyroid eye disease, also known as Graves’ orbitopathy or Graves' ophthalmopathy, is an eye condition that happens in a person with an overactive thyroid. Most eye surgeons (ophthalmologists) and hormone specialists (endocrinologists) will be in contact with an oculoplastic surgeon with experience in treating patients with thyroid eye disease.

What are the symptoms of graves eye disease?

Symptoms of Graves' eye disease include: Early symptoms — Feeling of irritation in the eyes, excessive tearing or dry eye, forward displacement of the eye, sensitivity to light and double vision Late symptoms — Swelling of the eye, inability to move the eye, corneal ulceration, and, rarely, loss of vision

Do subtypes of Graves' orbitopathy exist?

Do subtypes of graves' orbitopathy exist? N.I. Regensburg *, W.M ... To describe the prevalence of fat and muscle volume (MV) increase in Graves' orbitopathy (GO) patients, calculated from computed tomography scans, and the associated ophthalmic and endocrine characteristics. ... and group 4, both FV and MV increase (n = 8). Patients with an ...

What is the treatment for graves eye disease?

There are 3 ways Graves’ disease can be treated, including medicine and surgery

  • Radioactive iodine. Treatment with radioactive iodine, also called radioiodine, is the most common treatment for Graves’ disease.
  • Antithyroid medicines. ...
  • Surgery (Thyroidectomy) Thyroidectomy, or the complete or partial removal of the thyroid gland, is the least common form of Graves’ disease treatment.

image

What increases Orbitopathy in graves?

Risk factors for thyroid-associated orbitopathy include increased age of onset, duration of Graves hyperthyroidism, and smoking.

What is Grave's Orbitopathy?

Graves' orbitopathy is an autoimmune condition characterized by swelling of the tissue in the orbit (the area around the eyes), creating bulging of the eyes. It is commonly referred to as thyroid eye disease.

How do you treat Graves ophthalmopathy naturally?

10 Natural Ways to Combat Graves' DiseaseManage stress. ... Exercise regularly. ... Eat an anti-inflammatory diet. ... Eliminate toxins. ... Cut endocrine disrupting chemicals from your life. ... Use visualization exercises. ... Protect sensitive eyes and skin. ... Stay hydrated.More items...

Can graves Ophthalmopathy be reversed?

Many patients with mild to moderate Graves' ophthalmopathy will experience spontaneous improvement over the course of two to three years or will adapt to the abnormality. Severe ophthalmopathy will affect 10% of patients.

How do you treat Graves disease?

Mild symptoms of Graves' ophthalmopathy may be managed by using over-the-counter artificial tears during the day and lubricating gels at night. If your symptoms are more severe, your doctor may recommend: Corticosteroids. Treatment with corticosteroids, such as prednisone, may lessen swelling behind your eyeballs.

Can Graves disease go away?

Graves' disease is a lifelong condition. However, treatments can keep the thyroid gland in check. Medical care may even make the disease temporarily go away (remission): Beta-blockers: Beta-blockers, such as propranolol and metoprolol, are often the first line of treatment.

How long does graves Ophthalmopathy last?

Graves' eye disease usually affects both eyes, but you may only notice symptoms in 1 eye. Symptoms usually last 1 to 2 years and often go away on their own. In rare cases, swelling around the eyes can press on the optic nerve (the nerve that connects the eye to the brain) and cause vision loss.

How is thyroid eye treated?

Here are seven ways to ease the symptoms of thyroid eye disease.Use Lubricating Eye Drops. ... Ask Your Doctor if You Should Try a Selenium Supplement. ... Avoid Secondhand Smoke. ... Elevate Your Head. ... Try Taping. ... Wear Fresnel Prisms. ... Wear Sunglasses.

What helps swollen eyes from thyroid?

Keeping the head elevated in bed at night can help reduce swelling from the thyroid eye to a certain extent. Selenium supplements can help if eye swelling is mild. Medications such as steroids and immunosuppressants that treat inflammation also bring down the swelling.

Can Graves disease eyes go back to normal?

Some patients are left with permanent changes, and in others the eyes return to normal. A great deal can be done to improve these conditions with medical treatment, although some patients will need surgery to help ease their issues.

How do you improve Graves eye disease?

HOW IS GRAVES OPHTHALMOPATHY TREATED?Apply cool compresses to your eyes. ... Wear sunglasses. ... Use lubricating eyedrops. ... Elevate the head of your bed. ... Prisms: If double vision is a problem, glasses containing prisms may be prescribed by your doctor. ... Steroids. ... Eyelid surgery. ... Eye Muscle Surgery.More items...

What worsens Graves ophthalmopathy?

Background. Ophthalmopathy caused by Graves' disease may first appear or worsen during or after treatment for hyperthyroidism. It is not known, however, whether choosing to treat hyperthyroidism with antithyroid drugs, iodine-131, or surgery affects the development or aggravation of Graves' ophthalmopathy.

What is Graves' orbitopathy?

Graves' orbitopathy (ophthalmopathy) is an autoimmune disease of the retroorbital tissues. This topic review will provide an overview of the treatment of this d

Is UpToDate a substitute for medical advice?

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of UpToDate content is governed by the UpToDate Terms of Use. ©2021 UpToDate, Inc. All rights reserved.

Is Graves' orbitopathy a natural history?

The natural history of Graves' orbitopathy is variable and must be considered in the context of concomitant hyperthyroidism therapy [ 1-3].

How to treat Graves' ophthalmopathy?

Treating Graves' ophthalmopathy. Mild symptoms of Graves' ophthalmopathy may be managed by using over-the-counter artificial tears during the day and lubricating gels at night. If your symptoms are more severe, your doctor may recommend: Corticosteroids.

How to diagnose Graves disease?

To diagnose Graves' disease, your doctor may conduct a physical exam and check for signs and symptoms of Graves' disease. He or she may also discuss your medical and family history. Your doctor may also order tests including: Blood tests. Blood tests can help your doctor determine your levels of thyroid-stimulating hormone (TSH) ...

Why does thyroid shrink?

Because the thyroid needs iodine to produce hormones, the thyroid takes the radioiodine into the thyroid cells and the radiation destroys the overactive thyroid cells over time. This causes your thyroid gland to shrink, and symptoms lessen gradually, usually over several weeks to several months.

How does radioactive iodine affect thyroid function?

Your body needs iodine to make thyroid hormones. By giving you a small amount of radioactive iodine and later measuring the amount of it in your thyroid gland with a specialized scanning camera, your doctor can determine the rate at which your thyroid gland takes up iodine. The amount of radioactive iodine taken up by the thyroid gland helps determine if Graves' disease or another condition is the cause of the hyperthyroidism. This test may be combined with a radioactive iodine scan to show a visual image of the uptake pattern.

What is the best way to check thyroid gland?

Ultrasound. Ultrasound uses high-frequency sound waves to produce images of structures inside the body. It can show if the thyroid gland is enlarged. It's most useful in people who can't undergo radioactive iodine uptake, such as pregnant women.

What is the procedure to remove the thyroid gland?

Surgery to remove all or part of your thyroid (thyroidectomy or subtotal thyroidectomy) also is an option for the treatment of Graves' disease. After the surgery, you'll likely need treatment to supply your body with normal amounts of thyroid hormones.

What test can help with Graves disease?

Blood tests . Blood tests can help your doctor determine your levels of thyroid-stimulating hormone (TSH) — the pituitary hormone that normally stimulates the thyroid gland — and your levels of thyroid hormones. People with Graves' disease usually have lower than normal levels of TSH and higher levels of thyroid hormones.

What is Graves ophthalmopathy?

Graves ophthalmopathy (GO) is an inflammatory disorder of the orbit that occurs in association with autoimmune thyroid disease.1Al though most patients with GO have a history of Graves disease (GD) with hyperthyroidism, some are euthyroid with no such history or have hypothyroidism primarily caused by Hashimoto thyroiditis. 2A close temporal relationship exists between the onset of Graves hyperthyroidism and the onset of GO. Regardless of which condition occurs first, the other condition develops within 18 months in 80% of patients, although GO may occasionally precede or follow hyperthyroidism by many years.3The common manifestations of the disease vary considerably from patient to patient in expression, severity, and duration. Such signs include proptosis, upper eyelid retraction, and swelling with or without erythema of the periocular tissues, lids, and conjunctivae. The natural history of GO is characterized by fairly steady deterioration over 3 to 6 months, followed by a plateau phase of often between 1 and 3 years, then gradual improvement toward the baseline.4Whereas the inflammatory signs and symptoms generally resolve over time, proptosis, lid retraction, and extraocular dysfunction may persist. A cohort of patients with GO followed for a median of 12 months showed spontaneous improvement in ocular manifestations in approximately two-thirds, stability in 20%, and worsening in 14%.5

What is Graves's incidence rate?

The annual adjusted incidence rate of Graves hyperthyroidism is 0.50 per 1000 population, 12with some 25% to 50% of these patients having clinical eye involvement. Most patients with GO show mild signs and symptoms including corneal irritation, periocular swelling, eyelid retraction, conjunctival erythema/chemosis, and mild extraocular muscle dysfunction. A much smaller proportion of patients (approximately 5%) experience severe disease including significant inflammation/congestion, excessive proptosis, and sight-threatening corneal ulceration or optic neuropathy. Although GO is overall more frequent in women than in men, men are overly represented in severe forms of the disease, with a female-to-male ratio of 1:4.13Subclinical eye involvement is common, with approximately 70% of hyperthyroid patients showing evidence of GO on magnetic resonance imaging (MRI) or orbital computed tomography (CT) scanning.14The overall incidence of GO varies depending on the diagnostic criteria; the annual adjusted incidence rate of clinically significant GO in Olmsted County, Minnesota is 16 women and 3 men per 100,000 population.15A bimodal age distribution is followed, with peak incidence of GO in women occurring between age 40 to 44 years and 60 to 64 years, and in men between 45 to 49 years and 65 to 69 years. The other peripheral manifestations of GD, dermopathy and acropachy, occur with lower frequency and almost always develop in patients with more severe GO.16

How to manage GO?

Optimum management of GO requires a partnership between the endocrinologist and ophthalmologist, with the goal of preserving the patient’s vision and restoring favorable self-perception and QOL. Although either partner may make the diagnosis, the initial steps in management are generally the purview of the endocrinologist, who evaluates and addresses the reversible risk factors associated with disease progression and severity.13Smokers should be offered participation in a structured smoking cessation program, and patients exposed to second-hand smoke should be identified and advised of its negative impact.45If the patient is hyperthyroid, prompt attention should be directed toward the restoration of euthyroidism. Whereas RAI therapy with or without concurrent corticosteroid treatment for GO prophylaxis may be considered in nonsmokers with mild active GO, smokers who choose this treatment option should receive oral corticosteroids. A common regimen consists of prednisone (0.4–0.5 mg/kg/d) started 1 to 3 days following RAI administration and continued for 1 month, with tapering over the 2 subsequent months.17However, a recent retrospective cohort study suggested that lower doses of prednisone (0.2 mg/kg/d) for 6 weeks may be equally effective.46RAI treatment in patients with active and moderate or severe GO should be avoided in favor of either antithyroid drug therapy or thyroidectomy.45

Is IVGC therapy effective?

However, in summary it may be said that approximately 40% to 80% of GO patients treated with immunomodulatory therapy experience benefit, that patients with inactive disease are not likely to respond, and that IVGC therapy appears to be the most effective of the treatment options that have been well studied to date. Risks and benefits of these treatments should be carefully discussed with the patient who is best fully involved in the therapeutic decision-making process.

Does triiodothyronine increase risk?

Both high triiodothyronine and thyroxine levels increase risk (inconsistent results in the literature)

Does selenium help with GO?

Antioxidant therapy generally carries with it few side effects and may have a beneficial effect on GO outcome. An early intervention study consecutively assigned patients to allopurinol (300 mg daily) plus nicotinamide (300 mg daily) or placebo.48A promising result was noted in this nonrandomized study, with a total eye score index showing improvement in 82% of treated patients compared with 27% of those receiving placebo. Selenium was recently reported to improve mild GO in a trial conducted by the European Group on Graves Orbitopathy (EUGOGO) consortium.49Patients were randomized to receive selenium (100 µg twice daily), pentoxifylline, or placebo. Evaluation at 6 months, with confirmation at 12 months, documented an improvement not only in several ocular parameters but also in QOL, compared with placebo or pentoxifylline. The selenium-treated group did not experience any significant side effects, and in particular there was no increase in blood glucose levels, as has been noted in studies of selenium treatment in other diseases. An important caveat is that these subjects were from a population with marginally decreased selenium levels, leaving unanswered the question of selenium-related benefit in patients living in selenium-sufficient regions.

What is Graves orbitopathy?

Graves orbitopathy (Graves eye disease or Graves ophthalmopathy) is a constellation of signs and symptoms related to the orbit and surrounding tissues in patients with Graves disease. It can also sporadically occur in patients who are euthyroid or even hypothyroid as a result of chronic thyroiditis.[1]  It is an autoimmune process affecting retro-ocular tissues.[1]  In its severe form, it can be sight-threatening; thus, prompt evaluation and timely referral and management become of utmost importance.

What are the two pathways of Graves orbitopathy?

Fibroblasts are stimulated by TSH receptor antibodies as well as by T-cells (mediated by cytokine production) to initiate two pathways.[4]  The first is to produce glycosaminoglycans (GA Gs), the most pertinent of which is hyaluronic acid. The accumulation of these hydrophilic molecules leads to extraocular muscle swelling. The second pathway is through adipogenesis. Thus the combination of muscle swelling resulting in increased extraocular muscle volume with excess retro-ocular fat results in proptosis and the other clinical manifestations of Graves orbitopathy.

How long does Graves orbitopathy last?

One study showed that the development of moderate-to-severe orbitopathy over 18 months appeared in an average of 2.5% of patients. That same study showed 58% of patients with mild disease went into complete remission. [6]

How many people have Graves orbitopathy?

One study reported that the incidence of clinically apparent Graves orbitopathy was 16 per 100000 in females and 2.9 per 100000 in males. It is, however, also important to realize that an even larger proportion of patients may have MRI evidence of Graves orbitopathy in the absence of clinical disease. [6][7][8]

What are the risk factors for Graves disease?

Other risk factors include female gender, certain genetic factors (however, specific genes or mutations remain unidentified in having a direct causal relationship), and exposure to radioiodine as a treatment modality for Graves disease.[3] Smoking is the most significant modifiable risk factor. Graves eye disease tends to be more severe and less responsive to immunomodulatory therapy in those patients who smoke. The mechanism of how smoking is related to Graves eye disease is postulated to be by it affecting both humoral and cell-mediated immunity and suppression of natural killer T cells. [1]

What is the antibody that causes Graves disease?

The culprit antibody in Graves’ disease is the thyroid-stimulating hormone (TSH) receptor antibody . Its main site of action is on TSH receptors in the thyroid. However, TSH receptors are present in various extrathyroidal tissues. Evidence has suggested that the expression of the TSH receptor is in higher concentration in retro-ocular tissue in patients with Graves disease. [2]

How long is 20 Gy radiation?

Its proposed mechanism of action is on modulating the immune system. The most common regimen is a 2-week course of 10 sessions with a cumulative dose of 20Gy. [25]

WHAT ARE THE SYMPTOMS OF GRAVES OPHTHALMOPATHY?

Eye symptoms most often begin within 6 months of diagnosis of Graves’ disease. Very rarely eye problems may develop long after the thyroid disease has been treated. In some patients with eye symptoms, hyperthyroidism never develops and, rarely, patients may be hypothyroid. The severity of the eye symptoms is not related to the severity of the hyperthyroidism.

What is Graves' eye disease?

Graves’ eye disease, also called Graves’ Ophthalmopathy or Thyroid Eye disease, is a problem that usually develops in people with an overactive thyroid caused by Graves’ disease (See brochure on Graves’ disease ). Graves’ disease is an autoimmune disease caused by antibodies directed against receptors present in the thyroid cells and also on the surface of the cells behind the eyes. Rarely can also affect the skin, usually the front part of the legs. This usually results in a generalized over activity of the thyroid gland (hyperthyroidism). Up to one-half of people with Graves’ disease develop eye symptoms. These are usually mild and treatable.

What is orbital decompression surgery?

Orbital Decompression Surgery. When eyesight is threatened, a type of surgery called orbital decompression can be done. In this procedure, a bone between the eye socket (orbit) and sinuses is removed to allow more space for the swollen tissues. When the procedure is successful, it improves vision and provides room for your eyes to return to their normal position. There is a risk of complications, including double vision that persists or appears after surgery.

How to get rid of a swollen eye?

Apply cool compresses to your eyes . The extra moisture may provide relief.

What is the best treatment for swelling in the eye?

Steroids. Swelling in the eyes may be improved by treatment with steroids (such as hydrocortisone or prednisone)

Can you be hypothyroid with Graves' eye disease?

In some patients with eye symptoms, hyperthyroidism never develops and, rarely, patients may be hypothyroid. The severity of the eye symptoms is not related to the severity of the hyperthyroidism. Symptoms of Graves’ eye disease include: Feeling of irritation or grittiness in the eyes, redness or inflammation of the conjunctiva ...

Can Graves' eye disease be caused by thyroid?

Graves’ disease usually is associated with other symptoms of overactive thyroid. However, the classic symptoms of hyperthyroidism may not always be present. In fact, Graves’ eye disease can occur even when the thyroid is not overactive at that time. Graves’ eye disease often improves on its own. However, in some patients symptoms may persist ...

What is Graves' orbitopathy?

Graves’ ophthalmopathy (GO) is a thyroid eye disease ( or thyroid-associated oph thalmopathy) that can affect both vision and physical features. Another name for this ocular condition is Graves’ orbitopathy .

How long does Graves orbitopathy last?

Finally, although Graves’ orbitopathy can resolve within 1 to 2 years of onset, studies have shown a significant, negative impact on quality of life, mental health, and socioeconomic status.

What Does Thyroid Eye Disease Look Like?

This particular ocular disease will have standard clinical features, including:

What Eye Problems Can Graves' Disease Cause?

Graves’ disease is a serious health condition. In many cases, people with this disease can develop Graves’ ophthalmopathy.

What is Graves disease?

Graves’ disease is an autoimmune disease in which the body overproduces thyroid hormones, and the immune system responds negatively.

How to diagnose thyroid disease?

To diagnose the disease, doctors may perform one or multiple blood tests. They may also check for an enlarged thyroid and ask about a family history of thyroid or autoimmune problems.

How to check thyroid at home?

If you want to check your thyroid at home, you’ll need to have a mirror and glass of water at your disposal. Once you have both, take the mirror and hold it in front of you. Focus on the lower, front zone of the next.

image

Diagnosis

Treatment

  • The treatment goals for Graves' disease are to stop the production of thyroid hormones and to block the effect of the hormones on the body. Some treatments include:
See more on mayoclinic.org

Clinical Trials

  • Explore Mayo Clinic studiestesting new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.
See more on mayoclinic.org

Lifestyle and Home Remedies

  • If you have Graves' disease, make your mental and physical well-being a priority: 1. Eating well and exercisingcan enhance the improvement in some symptoms during treatment and help you feel better in general. For example, because your thyroid controls your metabolism, you may have a tendency to gain weight when the hyperthyroidism is corrected. Br...
See more on mayoclinic.org

Preparing For Your Appointment

  • You'll probably see your primary care doctor first. You may be referred to a specialist in disorders of hormone function and the endocrine system (endocrinologist). If you have Graves' ophthalmopathy, your doctor may also recommend that you see a doctor who has trained in eye disorders (ophthalmologist). Here's some information to help you get ready for your appointmen…
See more on mayoclinic.org

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9